rucaparib
clovis oncology
[]
 reversion mutation uncommon in #cfdna but indicates poorer outcome in pts with brca palb2 mutant (hrd) #pancreaticcancer kras detection also show outcome on parpi rucaparib maintenance by our colleagues &amp; tim brown at upenn powerhouse for pdac #gi23 
🗽 #NYC 🩺 #GI #oncologist @MSKCancerCenter #PancreaticCancer #BiliaryCancer #cancer 💜 #fan 🧬 #science #running #26.2 #research #trial #췌장담관암